Clinical Roundup NCCN pediatric cancer guidelines focus on improving long-term outcomes worldwide January 03, 2020Vol.46 No.01
Clinical Roundup SWOG study focuses on impact of vitamin and antioxidant supplement use in cancer patients January 03, 2020Vol.46 No.01
Clinical Roundup DREAMM-2 demonstrates meaningful ORR with belantamab mafodotin in multiple myeloma January 03, 2020Vol.46 No.01
Clinical RoundupFree PD-1 inhibitor treatment prior to stem cell transplant is safe, effective in classic Hodgkin lymphoma December 13, 2019Vol.45 No.46
Clinical RoundupFree BMS’s liso-cel met primary, secondary endpoints in TRANSCEND NHL 001 December 13, 2019Vol.45 No.46
Clinical RoundupFree Phase II KarMMa study of ide-cel in relapsed, refractory multiple myeloma meets ORR primary endpoint December 13, 2019Vol.45 No.46
Clinical RoundupFree Seattle Genetics announces positive OS, PFS, ORR for tucatinib in HER2+ breast cancer December 13, 2019Vol.45 No.46
Clinical RoundupFree ctDNA may help predict recurrence in patient with early triple-negative breast cancer December 13, 2019Vol.45 No.46
Clinical RoundupFree Extended follow-up phase III data underscore sustained efficacy and safety of Imbruvica in CLL December 13, 2019Vol.45 No.46
Clinical RoundupFree Phase III TOURMALINE-AL1 trial of Ninlaro in patients with amyloidosis didn’t meet one of two primary endpoints December 13, 2019Vol.45 No.46
